Sellers’ departure leaves the Knight Cancer Institute with interim leaders in the top two positions. Interim CEO Dr. Shivanni ...

The website you are visiting is protected and accelerated by Imperva. Your computer may have been infected by malware and ...

A new study reveals that the protein alpha-synuclein, known for its role in Parkinson’s disease, also contributes to the ...

Shivaani Kummar, MD, has been appointed interim chief executive of Portland-based Oregon Health and Science University’s Knight Cancer Institute. She will serve as interim chief until OHSU ...

A small protein involved in neurodegeneration leading to Parkinson's disease also drives a type of skin cancer known as melanoma, according to new research.

A new drug that helps slow the spread of an incurable type of breast cancer has been approved for use in Britain's state-run ...

One of the world’s leading cancer researchers is stepping down as CEO of the Knight Cancer Institute at Oregon Health and Science University. Dr. Brian Druker handed in his resignation on ...

Click here to read the full story. Dr. Brian Druker, who built the OHSU Knight Cancer Institute into a world class cancer research center, on Tuesday announced his resignation, saying that the ...

A twice-a-day pill for the most common type of advanced breast cancer has been approved on the NHS in what scientists say is a “landmark moment”.